Stay updated on Upadacitinib vs Abatacept in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Abatacept in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Abatacept in RA Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing v3.5.3. This indicates a small platform update rather than a change to the study information.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange Detected- The Sweden location entry now uses Malmö (with the diacritic) instead of Malmo, aligning the listing with the official city spelling. The postal code remains 214 28 and the rest of the details are unchanged.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a backend/content-system version change rather than any change to the trial information.SummaryDifference0.0%

- Check45 days agoChange DetectedKrakow, Lesser Poland Voivodeship, Poland, 30-149 is replaced by Cracow, Lesser Poland Voivodeship, Poland, 30-149. București is replaced by Bucharest, and a new Bucharest, Bucharest, Romania, 020475 entry is added; Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Abatacept in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Abatacept in RA Clinical Trial page.